Neurodermatitis of the scalp associated with trichotillomania treated with roflumilast cream 0.3%
Saved in:
Main Authors: | Edith Hanna, MD, Nour El Moussawi, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512624004880 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
by: Elena Carmona-Rocha, et al.
Published: (2025-01-01) -
Chronic nonscarring scalp folliculitis responding to topical phosphodiesterase-4 inhibitor roflumilast
by: Ekaterina Korytnikova, MD, et al.
Published: (2025-01-01) -
Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
by: Min Kyu Park, et al.
Published: (2025-01-01) -
Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01) -
Research progress on phosphodiesterase 4 inhibitors in the treatment of palmoplantar pustulosis
by: YAO Xinyi, et al.
Published: (2024-11-01)